Excretion of pantoprazole in human breast milk

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 49, Issue 10, 2004, Pages 825-827

  Plante, Lauren ^b   Ferron, Geraldine M ^b   Unruh, Mary ^b   Mayer, Philip R ^a  

^a PFIZER INC   (United States)

^b NONE

Author keywords

Breast milk; Pantoprazole

Indexed keywords

LANSOPRAZOLE; METOCLOPRAMIDE; OMEPRAZOLE; PANTOPRAZOLE; RANITIDINE; STOMACH SECRETION INHIBITOR;

ACIDITY; ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; BREAST MILK; CASE REPORT; DRUG BLOOD LEVEL; DRUG EXCRETION; DRUG EXPOSURE; FEMALE; GASTROINTESTINAL REFLUX; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MILK PRODUCTION; PH MEASUREMENT; PRIORITY JOURNAL; SIDE EFFECT;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; BENZIMIDAZOLES; BIOLOGICAL TRANSPORT, ACTIVE; BREAST FEEDING; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; MILK, HUMAN; OMEPRAZOLE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SULFOXIDES;

EID: 7244239517     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. Huber R, Müller W: High-performance liquid chromatographic determination of the H+/K+ ATPase inhibitor: By 1023/SK&F 96 022 and its sulphone metabolite in serum or plasma by direct injection and fully automated pre-column sample clean-up. J Chromatogr 1990;529:389-401
2. Begg EJ, Duffull SB, Hackett LP, et al: Studying drugs in human milk: Time to unify the approach. J Hum Lactation 2002;18:323-332
3. Marshall JK, Thompson AB, Armstrong D: Omeprazole for refractory gastroesophageal reflux disease during pregnancy and lactation. Can J Gastroenterol 1998;12:225-227